STOCKS SINK WITH FED IN FOCUS, AMAZON EARNINGS ON DECK

U.S. consumer confidence hits lowest level since July 2022

ABT Apr 2024 119.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

0.0100

0.0000

(0.00%)

As of 01:44PM EDT. Market open.

Loading interactive chart...

Zacks
PBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR Newswire
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
ACCESSWIRE
It's Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team
NORTHAMPTON, MA / ACCESSWIRE / April 23, 2024 / Abbott Eleven new HeartMates with 11 inspiring stories recognized at Abbott HeartMates Draft Day event in NYC. Abbott Just a week before the pro football draft, Abbott held a high-profile draft day experience ...